Merck & Co., US58933Y1055

Merck & Co. stock slips to EUR 125.65, down 1.31% premarket

Published on 11/19/2026 at 08:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Merck develops medicines and vaccines and also serves animal health markets. On Xetra, the stock closed at EUR 127.32 on Wednesday, November 18, 2026.

Merck's Healthcare Operations

  • Merck combines pharmaceuticals, preventive vaccines and animal health products.
  • The company serves healthcare providers, distributors, governments and livestock producers worldwide.
Merck & Co., US58933Y1055, Illustration mit AI erstellt.

Merck & Co. stock traded at EUR 125.65 on Lang & Schwarz at 08:08 CET on Thursday, November 19, 2026, 1.31 percent below the Xetra close of Wednesday, November 18, 2026.

The US healthcare company operates through pharmaceutical and animal health businesses. Its portfolio spans medicines for oncology, hospital care, immunology, virology and other therapeutic areas, alongside preventive vaccines and veterinary products.

Broader market developments are available through the S&P 500.

More news and analyses on Merck & Co. stock

Disclaimer...
en | US58933Y1055 | MERCK & CO. | boerse | 70534388 | bgmi